Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.348%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 23.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: JPMorgan ups Rio Tinto; Redburn likes Carnival

Thu, 14th Sep 2023 09:22

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

JPMorgan raises Anglo American price target to 2,900 (2,650) pence - 'overweight'

----------

JPMorgan raises Rio Tinto to 'neutral' (underweight) - price target 6,000 (5,440) pence

----------

Berenberg raises B&M European Value Retail price target to 645 (640) pence - 'buy'

----------

Investec raises Associated British Foods to 'add' (hold) - price target 2,195 (1,912) pence

----------

Bernstein raises Associated British Foods price target to 2,800 (2,600) pence - 'outperform'

----------

FTSE 250

----------

Berenberg raises Greggs price target to 3,440 (3,200) pence - 'buy'

----------

Berenberg cuts Energean price target to 1,555 (1,570) pence - 'buy'

----------

Berenberg raises Direct Line Insurance price target to 161 (152) pence - 'hold'

----------

JPMorgan raises Trainline price target to 295 (280) pence - 'neutral'

----------

UBS raises Redrow price target to 585 (565) pence - 'buy'

----------

Redburn Atlantic raises Carnival to 'buy' from 'neutral' - target price USD23

----------

SMALL CAP

----------

Jefferies raises THG price target to 105 (95) pence - 'buy'

----------

Berenberg raises Burford Capital price target to 1,600 (1,350) pence - 'buy'

----------

Berenberg cuts DFS Furniture price target to 155 (195) pence - 'buy'

----------

JPMorgan raises BHP Group price target to 2,550 (2,320) pence - 'neutral'

----------

Jefferies raises Angle price target to 75 (65) pence - 'buy'

----------

Jefferies cuts Frontier Developments price target to 520 (680) pence - 'buy'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more
11 Dec 2023 20:44

TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2023 11:50

IN BRIEF: Angle launches diagnostic kit at cancer symposium

Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium, following "extensive" development, optimisation and validation of the kit. Explains that the kit is read-to-use, and designed for the dentification, characterisation and enumeration of epithelial and mesenchymal cancer cells. This includes those undergoing epithelial-to-mesenchymal transition.

Read more
9 Nov 2023 14:29

Angle says build up of revenue slower than hoped; launches test

(Alliance News) - Angle PLC on Thursday said it expects revenue in 2023 to more than double from 2022 as it announced the launch of a new test aimed to support cancer therapy studies.

Read more
25 Oct 2023 17:28

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 Oct 2023 13:02

Angle hails study which shows Parsortix outperforming lab standard

(Alliance News) - Angle PLC on Tuesday touted the publication of a study by researchers at the University of Tubingen in Germany, which showed that its Parsortix system outperformed the current laboratory standard for disseminated tumour cell harvest.

Read more
7 Sep 2023 14:41

EARNINGS UPDATES: Sylvania beats production goal, Angle revenue surges

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News:

Read more
7 Sep 2023 11:20

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Sep 2023 14:21

Angle launches tumour cell assay to "unlock" customised cancer care

(Alliance News) - Angle PLC on Monday announced the launch of its new Portrait Flex circulating tumour cell assay, which it said will provide valuable trial data and help advance "personalised cancer care."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.